Table 1

cHSIL imiquimod cohort patient characteristics

Patient ID	Age	Response	Preimiquimod		10 weeks		20 weeks		6 months
Patient ID	Age	Response	Histology	HPV PCR	Histology	HPV PCR	Histology	HPV PCR	Cytology	HPV PCR
ERAS 001	30	CR	CIN2	Positive	CIN1	Positive	No dysplasia	Negative	PAP1	x
MUMC 001	31	CR	CIN2-3	Positive	No dysplasia	Negative	No dysplasia	Negative	PAP1	x
MUMC 014	36	CR	CIN2	Positive	CIN1	Negative	No dysplasia	Negative	PAP1	Negative
MUMC 018	25	CR	CIN3	Positive	CIN2	Negative	No dysplasia	Negative	PAP1	x
MUMC 034	30	CR	CIN3	Positive	CIN1	Negative	No dysplasia	Negative	PAP1	Negative
MUMC 040	36	CR	CIN2	Positive	CIN1	Negative	No dysplasia	Negative	PAP1	Positive
MUMC 044	30	CR	CIN2	Positive	CIN1	Negative	No dysplasia	Negative	PAP1	Negative
MUMC 078	36	CR	CIN3	Positive	No dysplasia	Negative	No dysplasia	Negative	PAP1	x
MUMC 081	30	CR	CIN3	Positive	CIN2	Positive	No dysplasia	Negative	PAP1	Negative
MUMC 027	26	CR	CIN2	Positive	CIN1	Weak +	CIN1	Negative	PAP1	Positive
CATH 017	31	CR	CIN3	Positive	No dysplasia	Negative	CIN1	Negative	PAP1	x
ERAS 002	30	CR	CIN3	Positive	CIN1	Negative	CIN2	Negative	PAP1	x
ERAS 004	52	CR	CIN3	Positive	CIN1	Negative	CIN1	Negative	PAP1	x
ERAS 016	32	CR	CIN2	Positive	No dysplasia	Negative	CIN1	Positive	PAP1	Negative
MUMC 010	30	CR	CIN3	Positive	No dysplasia	Negative	CIN1	Positive	PAP1	Negative
MUMC 036	30	CR	CIN3	Positive	CIN3	Positive	CIN2	Negative	PAP1	x
MUMC 049	31	CR	CIN2	Positive	CIN1	Negative	CIN1	Negative	PAP1	Negative
MUMC 062	30	CR	CIN3	Positive	No dysplasia	Negative	CIN1	Negative	PAP1	Negative
MUMC 065	31	CR	CIN3	Positive	CIN1	Positive	CIN1	Negative	PAP1	x
CATH 006	30	CR	CIN3	Positive	CIN2-3	Positive	x	x	PAP1	Positive
MUMC 080	28	CR	CIN3	Positive	CIN1	Negative	CIN1	Negative	PAP1	Positive
CATH 023	30	PR	CIN3	Positive	CIN1	Negative	PAP2	Positive	PAP2	Positive
ERAS 006	33	PR	CIN2	Positive	x	Negative	CIN1	Positive	PAP3A2	Positive
MUMC 037	35	PR	CIN3	Positive	CIN1	Positive	CIN2	Negative	PAP2	x
CATH 012	29	NR	CIN2	Positive	No dysplasia	Negative	CIN3	Positive	x	x
ERAS 010	30	NR	CIN2	Positive	CIN1	Negative	CIN3	x	PAP4	Positive
MUMC 002	30	NR	CIN3	Positive	CIN2	Negative	CIN3	Positive	PAP2	Negative
MUMC 003	29	NR	CIN3	Positive	CIN3	Positive	x	x	PAP1	Negative
MUMC 008	30	NR	CIN3	Positive	CIN3	Positive	CIN3	Positive	PAP1	Negative
MUMC 024	31	NR	CIN3	Positive	CIN3	Positive	x	x	PAP1	Positive
MUMC 038	28	NR	CIN3	Positive	CIN3	Positive	CIN2	Positive	PAP1	Negative
MUMC 045	55	NR	CIN2	Positive	CIN1	Positive	CIN2	Positive	PAP3A1	Positive
MUMC 051	59	NR	CIN2	Positive	CIN3	Positive	x	x	PAP1	Negative
MUMC 064	36	NR	CIN3	Positive	CIN1	Negative	CIN3	Positive	PAP3A1	Positive
MUMC 079	36	NR	CIN3	Positive	CIN2	Weak +	CIN2	Positive	PAP1	x

cHSIL, cervical high-grade squamous intraepithelial lesion; CIN, cervical intraepithelial neoplasia; CR, complete response; NR, no response; PAP, Papanicolaou dysplasia classification for cervix smear cytology; PR, partial response; x, sample not available.